• Skip to main content
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login

Alpha-9 Theranostics

Member Profile

Alpha 9 Theranostics is a clinical-stage biopharmaceutical company founded in 2019 by renowned scientists based at BC Cancer and the University of British Columbia.

The Company is using its world-class know-how in molecular design and targeting of radiotherapeutics to advance a portfolio of breakthrough technologies focused on the precision targeting of metastatic cancer. These technologies promise to potentially revolutionize the way in which metastatic cancer is both diagnosed and treated.

Sector
Biotechnology, Diagnostics, Medical Technology , Therapeutics
Area of Expertise
  • Imaging
  • Oncology
  • Radio Pharmaceuticals
  • Therapeutics
Company Stage Clinical Stage, Private Company, Series A Stage

Member Profile

Biotechnology, Diagnostics, Medical Technology , Therapeutics

Alpha-9 Theranostics

Bronze Sponsor

alpha 9 theranostics logo blue and orange
  • Website www.alpha9tx.com
  • Email info@alpha9tx.com
  • Address
    27 East 7th Ave
    Vancouver, BC
    V5T 1M4
  • Leadership Contact
    David Hirsch, CEO
    Follow us:
  • LinkedIn
  • News
  • Jobs

March 7, 2023

Alpha-9 Theranostics Strengthens its Scientific Expertise with Key Appointments to Leadership Team and Scientific Advisory Board

December 14, 2022

Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer

October 13, 2022

Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement

April 28, 2021

Alpha-9 Theranostics Announces $11 Million Series A Financing to Advance Portfolio of Radiotherapeutics and Diagnostics

October 30, 2020

Alpha-9 Theranostics Announces Successful Completion of Phase I/II Trial with A9T-1101 in patients with Neuroendocrine Tumours Diagnostic Imaging Candidate Confirms Utility of BF3 Technology

No current content.

  • Linkedin
Connect with us LinkedIn

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us